Pratyasha Ghosh1 and Mrinal K Ghosh2*
1CGHS, Kolkata, India
2Signal Transduction in Cancer and Stem Cells Laboratory, Division of Cancer Biology and
Inflammatory Disorder, Council of Scientific and Industrial Research-Indian Institute of
Chemical Biology (CSIR-IICB), Kolkata, India
*Corresponding Author: Mrinal K Ghosh, Signal Transduction in Cancer and Stem Cells Laboratory, Division of Cancer Biology and Inflammatory Disorder, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), Kolkata, India.
Received: March 31, 2020; Published: May 13, 2020
Outbreak of COVID-19 is caused by the novel coronavirus designated as 2019-nCoV or SARS-CoV-2. This super-spreader has proven to be devastating for health care systems. The trajectory of this outbreak is impossible to predict in any nation so far; effective response requires prompt action from the public and private health strategies for immediate development and implementation of effective treatment to counterattack the infective 2019-nCoV particles.
Citation: Pratyasha Ghosh and Mrinal K Ghosh. “2019-nCoV: Strategy to Combat the Ongoing Outbreak and Future Perspectives”.Acta Scientific Cancer Biology 4.6 (2020): 07-08.
Copyright: © 2020 Pratyasha Ghosh and Mrinal K Ghosh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
+91 9182824667
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
